RB1 and cancer: According to Emi Kishino et al., 2019, Palbociclib reduced Rb phosphorylation and cell growth in association with G1-S cell cycle blockade and the induction of cell senescence, but without increased apoptosis, and can slow the growth of cancer cells and delay cancer progression [110].